CymaBay Therapeutics Inc. (CBAY) Social Stream



CymaBay Therapeutics Inc. (CBAY): $32.23

0.06 (+0.19%)

POWR Rating

Component Grades

Momentum

C

Stability

F

Sentiment

Quality

C

Add CBAY to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#270 of 355

in industry

CYMABAY THERAPEUTICS INC (CBAY) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CBAY.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-17 8 $14 $7 $11.125 $23.95 -53.55%
2021-11-11 8 $14 $7 $11.25 $23.95 -53.03%
2022-03-18 8 $14 $9 $11.375 $23.95 -52.51%
2022-04-06 7 $14 $9.001 $11.375 $23.95 -52.51%
2022-05-13 7 $14 $9 $11.375 $23.95 -52.51%
2022-11-15 8 $14 $8 $10.5 $23.95 -56.16%
2022-12-14 8 $14 $8 $10.25 $23.95 -57.2%
2023-01-16 8 $17 $8 $10.75 $23.95 -55.11%
2023-01-31 8 $19 $8 $12 $23.95 -49.9%
2023-02-08 7 $19 $8 $12.25 $23.95 -48.85%
2023-03-16 8 $19 $8 $12.5 $23.95 -47.81%
2023-03-17 8 $19 $8 $12.75 $23.95 -46.76%
2023-03-20 8 $19 $8 $13.375 $23.95 -44.15%
2023-05-16 9 $19 $8 $13.75 $23.95 -42.59%
2023-06-30 9 $19 $8 $14.25 $23.95 -40.5%
2023-07-23 9 $19 $8 $14.666 $23.95 -38.76%
2023-07-31 10 $19 $12 $15.555 $23.95 -35.05%
2023-08-01 10 $19 $12 $16.333 $23.95 -31.8%
2023-08-11 11 $20 $12 $16.7 $23.95 -30.27%
2023-08-14 12 $22 $12 $17.636 $23.95 -26.36%
2023-08-24 12 $22 $15 $18.181 $23.95 -24.09%
2023-09-07 12 $33 $15 $20.181 $23.95 -15.74%
2023-09-08 12 $33 $18 $21.909 $23.95 -8.52%
2023-09-21 12 $33 $18 $22.09 $23.95 -7.77%
2023-09-26 12 $33 $19 $22.727 $23.95 -5.11%
2023-11-08 12 $33 $20 $24 $23.95 0.21%
2023-11-09 12 $34 $20 $24.454 $23.95 2.1%
2023-12-15 12 $34 $20 $24.818 $23.95 3.62%
2023-12-19 12 $34 $20 $25.454 $23.95 6.28%
2023-12-22 12 $34 $20 $26.5 $23.95 10.65%
2023-12-26 12 $34 $20 $26 $23.95 8.56%

The Trend in the Analyst Price Target


CBAY's average price target has moved up $16.6 over the prior 44 months.

CBAY reports an average of 39.06% for its upside potential over the past 49 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-07 8 19 8 12.500 9.02 38.58%
2023-06-14 9 19 8 14.250 8.72 63.42%
2023-06-30 9 19 8 14.250 10.95 30.14%
2023-08-14 12 22 12 17.636 12.07 46.11%
2023-12-19 12 34 20 25.454 22.63 12.48%

CBAY Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 12 0 0 0 0 12

The Trend in the Broker Recommendations


Over the past 19 months, CBAY's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, CYMABAY THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 317.51% of them.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, CYMABAY THERAPEUTICS INC's number of analysts covering the stock is greater than 3713.67% of them.
  • CBAY has a higher average analyst price target than 1096.41% of Healthcare stocks.
  • CBAY has a lower variance in analysts' estimates than -2568.4% of stocks in the small market cap category.

In the Pharmaceutical Products industry, RMTI, RIGL, and ANIP are the three stocks most similar to CYMABAY THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

Is CBAY a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!